Indaptus Therapeutics launches $100 million ATM equity program
Indaptus Therapeutics entered an amended and restated at-the-market offering agreement for flexible equity access, allowing sales of up to $100 million of common stock. H.C. Wainwright acts as sales agent and potentially as principal.
Indaptus Therapeutics entered into an amended and restated at-the-market offering agreement to provide flexible access to equity capital.
The program allows sales of up to $100 million of common stock, with H.C.
Wainwright acting as sales agent and potentially as principal.
Shares may be sold from…